Latest Generx Stories
SAN DIEGO, March 3, 2014 /PRNewswire/ -- Cardium Therapeutics Inc.
SAN DIEGO, Jan. 27, 2014 /PRNewswire/ -- Cardium Therapeutics Inc.
Clinical and Preclinical Results Have Implications for Use of Generx as a Non-Surgical Gene Therapy for Coronary Artery Disease, and Excellagen to Potentiate Stem Cell Therapies SAN
SAN DIEGO, June 15, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that it has received clearance from the Russian Ministry of Health and Social Development to commence a Phase 3 registration study for the Company's Generx(TM) (alferminogene tadenovec, Ad5FGF-4) biologic product candidate.
- A poem in which the author retracts something said in an earlier poem.